MARKET

SWAV

SWAV

SHOCKWAVE MEDICAL, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

71.95
+1.66
+2.36%
After Hours: 71.95 0 0.00% 16:00 09/25 EDT
OPEN
70.36
PREV CLOSE
70.29
HIGH
72.93
LOW
69.39
VOLUME
368.47K
TURNOVER
--
52 WEEK HIGH
73.81
52 WEEK LOW
22.01
MARKET CAP
2.45B
P/E (TTM)
-34.0963
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Checks have BofA staying bullish on medtech names as demand shores up
A couple of weeks of diligence calls has led to an update on medical technology from BofA, where it changes a few ratings (mainly on valuation), raises a few price
Seekingalpha · 09/08 23:30
The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2)
Benzinga · 09/03 11:55
The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)
Benzinga · 09/02 11:25
The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31)
Benzinga · 09/01 12:35
The Daily Biotech Pulse: Modrerna Japanese Vaccine Deal Talk, Lipocine FDA Decision, Liver Congress Presentations
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 27)
Benzinga · 08/28 12:26
Shockwave Medical to Participate in Upcoming September Investor Conferences
SANTA CLARA, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that Shockwave management is scheduled to speak at the following upcoming virtual
GlobeNewswire · 08/26 13:00
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Data, Sorrento To Buy R&D Partner, Kymera IPO
  Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 20)
Benzinga · 08/21 11:43
The Daily Biotech Pulse: Poseida's Phase 1 Study Placed On Clinical Hold, Orphan Drug Designation For Krystal Biotech, Tiziana's Patent Award
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17)
Benzinga · 08/18 12:21
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SWAV. Analyze the recent business situations of SHOCKWAVE MEDICAL, INC. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SWAV stock price target is 68.20 with a high estimate of 80.00 and a low estimate of 55.00.
EPS
Institutional Holdings
Institutions: 188
Institutional Holdings: 29.29M
% Owned: 86.13%
Shares Outstanding: 34.00M
TypeInstitutionsShares
Increased
50
3.73M
New
67
1.31M
Decreased
21
1.41M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+2.16%
Healthcare Equipment & Supplies
+2.01%
Key Executives
Chairman/Independent Director
C. Raymond Larkin
President/Chief Executive Officer/Director
Douglas Godshall
Chief Financial Officer
Dan Puckett
Chief Financial Officer
Daniel Puckett
Other
Keith Dawkins
Other
Isaac Zacharias
Director
Maria Sainz
Independent Director
Colin Cahill
Independent Director
Laura Francis
Independent Director
Frederic Moll
Independent Director
Antoine Papiernik
Independent Director
F. Thomas Watkins
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SWAV
ShockWave Medical, Inc. is a medical device company. The Company is focused on developing and commercializing products and establish care for medical device treatment of atherosclerotic cardiovascular disease. Its IVL System, which leverages IVL Technology, is a minimally invasive and improve patient outcomes. IVL System includes a generator, connector cable and a variety of IVL catheters designed to treat PAD and CAD. IVL Technology to crack calcium through short bursts of sonic pressure waves, which are generated within the IVL catheter, travel through the vessel and crack calcium with an effective pressure of up to 50 atmospheres (atm) (a unit of pressure) without harming the soft tissue.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Shockwave Medical Inc stock information, including NASDAQ:SWAV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SWAV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SWAV stock methods without spending real money on the virtual paper trading platform.